Journal List > Yonsei Med J > v.60(10) > 1133231

Cha, Oh, and Song: Impacts of Financial Coverage on Long-Term Outcome of Intensive Care Unit Survivors in South Korea

Abstract

Purpose

The objective of this study was to investigate whether financial coverage by the national insurance system for patients with lower economic conditions can improve their 1-year mortality after intensive care unit (ICU) discharge.

Materials and Methods

This study, conducted in a single tertiary hospital, used a retrospective cohort design to investigate discharged ICU survivors between January 2012 and December 2016. ICU survivors were classified into two groups according to the National Health Insurance (NHI) system in Korea: medical aid program (MAP) group, including people who have difficulty paying their insurance premium or receive medical aid from the government due to a poor economic status; and NHI group consisting of people who receive government subsidy for approximately 2/3 of their medical expenses.

Results

After propensity score (PS) matching, a total of 2495 ICU survivors (1859 in NHI group and 636 in MAP group) were included in the analysis. Stratified Cox regression analysis of PS-matched cohorts showed that 1-year mortality was 1.31-fold higher in MAP group than in NHI group (hazard ratio: 1.31, 95% confidence interval, 1.06 to 1.61; p=0.012). According to Kaplan-Meir estimation, MAP group also showed significantly poorer survival probability than NHI group after PS matching (p=0.011).

Conclusion

This study showed that 1-year mortality was higher in ICU survivors with low economic status, even if financial coverage was provided by the government. Our result suggests the necessity of a more nuanced and multifaceted approach to policy for ICU survivors with low economic status.

INTRODUCTION

Compared to the past, hospital mortality of critically ill patients admitted to the intensive care unit (ICU) has continued to decrease, owing to advances in critical medicine and patient management.123 In other words, the number of ICU survivors is continuing to increase. However, ICU survivors experience posttraumatic stress, depression, cognitive impairment, and physical weakness; and are known to have poorer long-term survival outcomes compared to the general population.145 Therefore, improving the long-term outcomes of ICU survivors remains a very important issue today.67 Nevertheless, it is a very challenging task which requires the efforts of individual patients, their guardians, and the society as a whole.89
Financial burden is one of the biggest and most common stress factors that ICU survivors face while experiencing critical illness.10 This burden also impacts their caregivers, and is a serious problem that can cause psychological stress. A recent observational study conducted in two academic hospitals in New York City reported that race or ethnicity was not associated with long-term mortality among ICU survivors, while insurance status was closely associated.11 In other words, the lack of insurance coverage was associated with increased mortality among ICU survivors, and thus this study has emphasized the need for the provision of appropriate financial coverage for ICU survivors. However, it remains uncertain whether complete financial coverage through the insurance system can improve long-term mortality among patients with lower economic status, since there has been no study to date on this topic. Determining whether the long-term outcomes of ICU survivors with lower economic status can be sufficiently improved through financial support may be helpful in establishing suitable policies targeting these ICU survivors.
Accordingly, the objective of the present study was to investigate whether complete financial coverage by the national insurance system for patients with lower economic status is associated with improvement of 1-year mortality after ICU discharge. We hypothesized that ICU survivors with lower economic status, who receive complete financial coverage, will experience an improvement in 1-year mortality after ICU discharge, as compared to regular patients.

MATERIALS AND METHODS

Ethical statement, design, and setting

This retrospective cohort study was conducted with approval from the Institutional Review Board (IRB) of Seoul National University Bundang Hospital (SNUBH) (IRB approval number: B-1902/522-105). Considering the nature of a retrospective cohort study that involves analysis of medical records of patients who have already completed their treatment, the requirement for informed consent was waived by the IRB.

Data source

The present study used electronic health records stored in Seoul National University Bundang Hospital Electronic System for Total Care (BESTCare), which is the electronic medical record system of SNUBH, as the data source.12 Moreover, the date of death and cause of death of all patients, including follow-up loss patients, were collected from the database of Statistics Korea (http://kostat.go.kr/portal/eng). The causes of death were classified according to the Korean standard classification of disease and cause of death (KCD) 7th edition supplied by Statistics Korea.

Study population

The study population in the present study consisted of discharged adult ICU survivors who were 18 years or older and had been admitted to the ICU between January 2012 and December 2016. Only the last ICU admission of patients who had been admitted to the ICU more than once was considered for analysis. Among the ICU survivors, foreign patients who were not enrolled in the insurance system of South Korea, patients admitted to the ICU with industrial accident compensation insurance or car insurance, as well as patients with incomplete or missing medical records, were excluded from the analysis.

Health insurance system in South Korea as an independent variable

Since 1989, all South Korean citizens have been required to enroll in the National Health Insurance (NHI) system provided by the government.13 Most citizens pay a fixed rate of health insurance premium based on their income, with approximately 2/3 of their medical expenses subsidized by the government. In addition, foreigners who stay in South Korea for a certain period (6 months or longer) may also enroll for NHI service. However, patients who are too poor to pay their insurance premium or have difficulty in financially supporting themselves belong to the medical aid program (MAP), through which the government covers almost all medical expenses to reduce the burden of medial cost on these patients. Specifically, the patients in MAP were classified as type 1 MAP and type 2 MAP depending on their income, property, and other factors. Specifically, type 1 MAP patients included workers with inability to work, households with rare incurable diseases, recipients of subsidized housing, patients of national merit, and North Korea defectors. Type 2 MAP group included low-income people unable to live independently, but not meeting the type 1 MAP conditions. The government pays for 100% of the medical costs for patients in type 1 MAP group, and 85% of costs for those in type 2 MAP group. According to a recent Profile of National Cohort in South Korea, the percentage of males and females enrolled in the total MAP was 2.5% and 3.4%, respectively.14

Study endpoints

The primary endpoint in the present study was 1-year mortality after ICU discharge. The secondary endpoint was the cause of death (e.g., cardiovascular disease, cancer, neurological disease, injury, or trauma) related to the 1-year mortality after ICU discharge.

Covariates

Data collected included 1) physical characteristics [sex, age, and body mass index (BMI, kg/m2)]; 2) information regarding socioeconomic status [highest educational attainment (lower than high school/more than or equal to high school, lower than college/more than or equal to college) and marital status (unmarried/ married or living with someone/divorced or separated/ widowed)], 3) Acute Physiology and Chronic Health Evaluation (APACHE) II; 4) comorbidities [hypertension, diabetes mellitus, history of coronary disease and cerebrovascular disease, liver disease (hepatitis, liver cirrhosis, and fatty liver), chronic obstructive lung disease, chronic kidney disease, and cancer]; and 5) admitting department (internal medicine or emergency medicine/neurologic center/cardiothoracic surgical department/ other surgical department). For collection of comorbidity-related information, International Classification of Disease 10th Revision (ICD-10) diagnostic system was used in this study.

Statistical analysis

Baseline characteristics of the ICU survivors were presented as the mean with standard deviation or numbers with percentage. First, we performed propensity score (PS) matching, which is known to minimize the influence of confounders in cohort studies.15 PS matching was performed using the nearest neighbor method with 1:3 ratio and no replacement by caliper 0.2. Absolute value of standardized mean difference (ASD) was used to assess the balance between NHI and MAP groups before and after PS matching. All covariates (age, BMI, sex, highest educational attainment, marital status, APACHE II, hypertension, diabetes mellitus, history of coronary artery disease and cerebrovascular disease, liver disease, chronic obstructive lung disease, chronic kidney disease, cancer, admitting department, and year of ICU discharge) were included in PS model. Our goal was to match all confounders between the two groups to obtain an ASD of <0.1 through PS matching. After confirming a good balance between the two groups in the PS-matched cohort, we performed stratified Cox regression analysis for 1-year mortality after ICU discharge for conditional Cox regression. We also performed a competing risk analysis to investigate differences in hazard between NHI and MAP groups, based on the four types of 1-year mortality according to the cause of death (death related to cardiovascular disease, cancer, neurologic disease, or injury or trauma) in the PS-matched cohort.
Next, we performed a multivariable Cox regression analysis on the entire cohort for the following two reasons: first, to determine whether the findings in the PS-matched cohort were generalizable for the entire cohort; and second, to determine the associations with 1-year mortality in the same context as all covariables without dividing the ICU survivors by insurance type. Additionally, we performed Cox regression analysis in both PS-matched cohort and entire cohort after multivariable adjustment by dividing the total MAP group into two groups (Type 1 MAP and Type 2 MAP) for sensitivity analysis. Finally, the overall survival times after ICU discharge of MAP group and NHI group are presented as Kaplan-Meir curves generated from data before and after PS matching, and log-rank test was used to test statistical significance. All resulting values of the Cox regression models are presented as hazard ratios (HRs) and confidence intervals (CIs), and the log-minus-log plot function was used to determine whether each Cox proportional hazard model satisfied the central assumption. Concordance (C) statistics were used to identify the C-index of the multivariable Cox regression model. All analyses were performed using R software (version 3.6.0; R Foundation for Statistical Computing, Vienna, Austria), and p<0.05 was considered statistically significant.

RESULTS

Between January 2012 and December 2016, there were 34245 total ICU admissions involving 25079 unique patients. After excluding multiple ICU admissions of the same patient (n=9166), the last episode of ICU admissions of 25079 patients were included in the analysis. From this patient population, the following patients were excluded: 4925 children aged under 18 years; 108 foreigners not covered by insurance; 300 patients admitted to the ICU with industrial accident compensation insurance or car insurance; 323 patients discharged from the ICU after December 2016; 1505 patients who died during their stay in the ICU; and 148 patients with incomplete or missing medical records. As a result, 17770 ICU survivors were included in the analysis, with 17130 patients (96.4%) in NHI group and 640 patients (3.6%) in MAP group. After performing PS matching to balance the two groups, a total PS matching of 2495 ICU survivors (NHI group: 1859; MAP group: 636) were included in the final analysis (Fig. 1). Comparison results of the characteristics of ICU survivors between NHI and MAP groups before and after PS matching are shown in Table 1. After PS matching, two groups were well-balanced with ASD <0.1, while the distribution of PS after PS matching was similar to that before PS matching (Supplementary Fig. 1, only online).

Survival analysis after PS adjustment

The analysis results of 1-year mortality among ICU survivors in PS-matched cohort are shown in Table 2. The results showed 1-year mortality of 289/1880 (15.5%) and 127/636 (20.0%) in NHI and MAP groups, respectively. In the stratified Cox regression model, MAP group showed 1.31-fold higher 1-year mortality than NHI group (HR: 1.31, 95% CI: 1.06 to 1.61; p=0.012). Kaplan-Meir curves for 1-year mortality before (A) and after (B) PS matching are shown in Fig. 2, in which MAP group showed significantly poorer survival probability than NHI group both before and after PS matching (Fig. 2A, p<0.001; and Fig. 2B, p=0.011 by log-rank test). In sensitivity analysis in PS-matched cohort, type 1 MAP group showed 1.36-fold higher 1-year mortality (HR: 1.36, 95% CI: 1.10 to 1.68, p=0.004), while type 2 MAP group did not show significant 1-year mortality, compared to NHI group (p=0.168). A competing risk analysis using the PS-matched cohort showed that 1-year mortality rates after ICU discharge due to cardiovascular disease, cancer, neurological disease, and injury or trauma were not significantly different between the two groups (all p>0.05 in Table 2).

Survival analysis after multivariable adjustment in entire cohort

The results of sensitivity analysis using multivariable Cox regression models for the entire cohort are presented in Table 3. MAP group showed 1.26-fold higher 1-year mortality than NHI group (HR: 1.26, 95% CI: 1.05 to 1.51, p=0.015). C-index of multivariable model was 0.82 (95% CI: 0.81 to 0.83). In sensitivity analysis using the entire cohort, type 1 MAP group showed 1.25-fold higher 1-year mortality (HR: 1.25, 95% CI: 1.04 to 1.51, p=0.017), while type 2 MAP group did not show significant 1-year mortality compared to NHI group (p=0.574).

DISCUSSION

The findings in the present study showed that the ICU survivors in MAP group, who were poor but received financial coverage from the government for most of their medical expenses, experienced higher 1-year mortality after ICU discharge compared to other ICU survivors in NHI group. Additionally, this association was more pronounced in type 1 MAP group, who might represent more difficult economic circumstances than type 2 MAP group. In other words, the findings in the present study showed that providing financial coverage alone cannot improve the long-term outcomes of ICU survivors with lower economic status, and that a more nuanced and multifaceted policy approach is needed for such patients. A competing risk analysis revealed no significant difference in specific cause of death between the two groups.
Despite sufficient financial coverage, the higher 1-year mortality among ICU survivors with lower economic status has many reasons. The first reason is the issue of frailty, which is the loss of physiologic or cognitive reserve. Recent reports have indicated that patients with lower socioeconomic status tend to be more frail.1617 Pre-ICU admission frailty status is a scale that can predict the prognosis of ICU survivors,18 while increase in such frailty is known to be associated with increase in long-term mortality.19 It is possible that pre-ICU admission frailty may have been more common among patients with lower economic status in the present study (MAP group), which may be associated with higher 1-year mortality among ICU survivors in MAP group.
Second, the utilization of healthcare source may have been different between MAP and NHI groups. According to the behavioral model by Andersen,20 three major factors that trigger the utilization of health care source are individual needs, enabling factors, and predisposing factors. In the present study, MAP group addressed the enabling factor by receiving financial coverage; however, because marital status or final educational attainment was matched through PS, predisposing factor did not have a significant influence on healthcare utilization. Therefore, the possible source of problem in the present study may have been individual needs of the patients. ICU survivors commonly experience unplanned hospital readmissions after discharge;21 as a result, they often require continued health care utilization. In addition, strict compliance to prescribed medication would be essential for improving long-term outcomes of ICU survivors. While additional studies may be needed on this topic, patients with lower economic status in MAP group may have had little need for treatment, despite having sufficient financial coverage.
Another noteworthy finding was in the multivariable Cox regression models including all covariates. Overall, 1-year mortality increased independently in patients with comorbidities such as cancer, chronic kidney disease, cerebrovascular disease, or liver disease. Such finding was consistent with previous studies reporting that preexisting comorbidity played an important role in the prognosis of ICU survivors.21 Moreover, the unmarried group in this study showed the association of independently increased 1-year mortality compared to married group. This finding was consistent with previous studies reporting that the role and burden of caregivers may be higher for ICU survivors;22 moreover, when the behavioral model by Andersen was applied, family was found to be an important predisposing factor on the outcomes of ICU survivors.20 As a result, the significance of the present study is that it used PS matching to investigate the association between complete financial coverage for ICU survivors with very low economic status and 1-year mortality, and revealed factors associated with insurance status through multivariable Cox models including various variables.
Our study implies that insurance status, such as MAP or NHI, was not determinative of long-term mortality among ICU survivors, though it might reflect the patients' level of frailty upon returning to community. As previous studies reported, insurance status reflects the level of frailty, especially when it is representative of economic status.2324 Therefore, association between MAP group and increased 1-year mortality after ICU discharge should be interpreted carefully in this context. Additionally, our sensitivity analysis showed that type 1 MAP group, and not type 2 MAP group, was associated with higher 1-year mortality, despite receiving a higher level of financial coverage rate than type 2 MAP group. These results suggest that frailty status upon ICU discharge has more predictive value than financial coverage.
The present study had some limitations. First, the limitation of using a retrospective cohort design may have caused some selection bias. Second, since this was a single-center, single-country study, the findings cannot be generalized. As South Korea has relatively good insurance coverage for its citizens through its NHI service, direct comparisons with other countries would be difficult. Third, the proportion of patients with lower economic status belonging to MAP group was very small in the present study, and it was inevitable that a lot of samples were discarded through PS matching in this study. Fourth, we did not consider the difference in income levels of patients within NHI group, as specific and individual income level was not collected at our institution to protect the privacy of individual patients. The spectrum of economic status represented by NHI group might be broad, which might affect our results. Lastly, since the two groups differed in economic status, the treatments received in the ICU might be different. For example, MAP group would not have received the same treatment as non-reimbursable ones. Therefore, the lack of analysis of the treatment levels associated with insurance types was an important limitation of this study.
In conclusion, this retrospective cohort study showed that ICU survivors with low economic status experience higher 1-year mortality. Our results suggest the necessity of a more nuanced and multifaceted approach to policy for ICU survivors with low economic status.

Notes

The authors have no potential conflicts of interest to disclose.

AUTHOR CONTRIBUTIONS:

  • Conceptualization: Tak Kyu Oh and Jun Kwon Cha.

  • Data curation: In-Ae Song and Jun Kwon Cha.

  • Formal analysis: Tak Kyu Oh.

  • Funding acquisition: Jun Kwon Cha.

  • Investigation: Tak Kyu Oh.

  • Methodology: Tak Kyu Oh and Jun Kwon Cha.

  • Project administration: In-Ae Song.

  • Resources: Jun Kwon Cha.

  • Software: Tak Kyu Oh.

  • Supervision: Tak Kyu Oh.

  • Validation: Tak Kyu Oh.

  • Visualization: Jun Kwon Cha.

  • Writing—original draft: Jun Kwon Cha.

  • Writing—review & editing: Tak Kyu Oh and In-Ae Song.

References

1. Brinkman S, de Jonge E, Abu-Hanna A, Arbous MS, de Lange DW, de Keizer NF. Mortality after hospital discharge in ICU patients. Crit Care Med. 2013; 41:1229–1236. PMID: 23591209.
crossref
2. Goldhill DR, Sumner A. Outcome of intensive care patients in a group of British intensive care units. Crit Care Med. 1998; 26:1337–1345. PMID: 9710091.
crossref
3. Moreno R, Morais P. Outcome prediction in intensive care: results of a prospective, multicentre, Portuguese study. Intensive Care Med. 1997; 23:177–186. PMID: 9069003.
crossref
4. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010; 38:1276–1283. PMID: 20308885.
crossref
5. Sukantarat KT, Williamson RC, Brett SJ. Psychological assessment of ICU survivors: a comparison between the Hospital Anxiety and Depression scale and the Depression, Anxiety and Stress scale. Anaesthesia. 2007; 62:239–243. PMID: 17300300.
crossref
6. Schofield-Robinson OJ, Lewis SR, Smith AF, McPeake J, Alderson P. Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors. Cochrane Database Syst Rev. 2018; 11:CD012701. PMID: 30388297.
crossref
7. Gayat E, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Damoisel C, et al. Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study. Crit Care. 2018; 22:8. PMID: 29347987.
crossref
8. Lone NI, Gillies MA, Haddow C, Dobbie R, Rowan KM, Wild SH, et al. Five-year mortality and hospital costs associated with surviving intensive care. Am J Respir Crit Care Med. 2016; 194:198–208. PMID: 26815887.
crossref
9. Garland A, Olafson K, Ramsey CD, Yogendran M, Fransoo R. A population-based observational study of intensive care unit-related outcomes. With emphasis on post-hospital outcomes. Ann Am Thorac Soc. 2015; 12:202–208. PMID: 25706486.
crossref
10. Khandelwal N, Hough CL, Downey L, Engelberg RA, Carson SS, White DB, et al. Prevalence, risk factors, and outcomes of financial stress in survivors of critical illness. Crit Care Med. 2018; 46:e530–e539. PMID: 29505422.
crossref
11. Baldwin MR, Sell JL, Heyden N, Javaid A, Berlin DA, Gonzalez WC, et al. Race, ethnicity, health insurance, and mortality in older survivors of critical illness. Crit Care Med. 2017; 45:e583–e591. PMID: 28333761.
crossref
12. Yoo S, Lee KH, Lee HJ, Ha K, Lim C, Chin HJ, et al. Seoul National University Bundang Hospital's electronic system for total care. Healthc Inform Res. 2012; 18:145–152. PMID: 22844650.
crossref
13. Song YJ. The South Korean health care system. JMAJ. 2009; 52:206–209.
14. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017; 46:e15. PMID: 26822938.
crossref
15. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984; 79:516–524.
crossref
16. Franse CB, van Grieken A, Qin L, Melis RJF, Rietjens JAC, Raat H. Socioeconomic inequalities in frailty and frailty components among community-dwelling older citizens. PLoS One. 2017; 12:e0187946. PMID: 29121677.
crossref
17. Szanton SL, Seplaki CL, Thorpe RJ Jr, Allen JK, Fried LP. Socioeconomic status is associated with frailty: the Women's Health and Aging Studies. J Epidemiol Community Health. 2010; 64:63–67. PMID: 19692719.
crossref
18. Ferrante LE, Pisani MA, Murphy TE, Gahbauer EA, Leo-Summers LS, Gill TM. The Association of Frailty With Post-ICU Disability, Nursing Home Admission, and Mortality: a longitudinal study. Chest. 2018; 153:1378–1386. PMID: 29559308.
19. Bagshaw SM, Stelfox HT, Johnson JA, McDermid RC, Rolfson DB, Tsuyuki RT, et al. Long-term association between frailty and health-related quality of life among survivors of critical illness: a prospective multicenter cohort study. Crit Care Med. 2015; 43:973–982. PMID: 25668751.
20. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995; 36:1–10. PMID: 7738325.
crossref
21. Lone NI, Lee R, Salisbury L, Donaghy E, Ramsay P, Rattray J, et al. Predicting risk of unplanned hospital readmission in survivors of critical illness: a population-level cohort study. Thorax. 2018; 4. 05. DOI: 10.1136/thoraxjnl-2017-210822. [Epub].
crossref
22. van Beusekom I, Bakhshi-Raiez F, de Keizer NF, Dongelmans DA, van der Schaaf M. Reported burden on informal caregivers of ICU survivors: a literature review. Crit Care. 2016; 20:16. PMID: 26792081.
crossref
23. Guessous I, Luthi JC, Bowling CB, Theler JM, Paccaud F, Gaspoz JM, et al. Prevalence of frailty indicators and association with socioeconomic status in middle-aged and older adults in a swiss region with universal health insurance coverage: a population-based crosssectional study. J Aging Res. 2014; 2014:198603. PMID: 25405033.
crossref
24. Lu Y. Dynamic frailty count process in insurance: a unified framework for estimation, pricing, and forecasting. J Risk Insur. 2018; 85:1083–1102.
crossref

SUPPLEMENTARY MATERIAL

Supplementary Fig. 1

Distribution of propensity scores before and after propensity score matching. NHI, National Health Insurance; MAP, medical aid program.
ymj-60-976-s001.pdf
Fig. 1

Flow chart depicting patient selection. ICU, intensive care unit.

ymj-60-976-g001
Fig. 2

Kaplan-Meir curve of overall survival after intensive care unit (ICU) discharge before (A) and after (B) propensity score matching.

ymj-60-976-g002
Table 1

Characteristics of ICU Survivors before and after Propensity Score Matching

ymj-60-976-i001
Variables Entire cohort (n=17770) PS-matched cohort (n=2495)
NHIP (n=17130) MAP (n=640) ASD NHIP (n=1859) MAP (n=636) ASD
Age (yr) [mean (standard deviation)] 62.8 (15.5) 66.0 (16.3) 0.196 23.1 (3.6) 23.0 (3.9) 0.005
Sex (male) 10229 (59.7) 315 (49.2) 0.209 943 (50.7) 315 (49.5) 0.026
BMI (kg m−2) [mean (standard deviation)] 23.8 (3.4) 23.0 (3.9) 0.195 23.1 (3.6) 23.0 (3.9) 0.004
Highest educational attainment 0.558 0.019
 Lower than high school 6530 (38.1) 388 (60.6) 1109 (59.7) 384 (60.4)
 More than or equal to high school, lower than college 4780 (27.9) 160 (25.0) 461 (24.8) 160 (25.1)
 More than or equal to college 5820 (34.0) 92 (14.4) 289 (15.5) 92 (14.5)
Marital status 0.537 0.011
 Never married 1067 (6.2) 81 (12.6) 219 (11.8) 79 (12.4)
 Married or living with someone 14053 (82.0) 354 (55.3) 1072 (57.6) 354 (55.7)
 Divorced or separated 420 (2.5) 81 (12.6) 200 (10.8) 79 (12.4)
 Widowed 1590 (9.3) 124 (19.4) 368 (19.8) 124 (19.5)
APACHE II [mean (standard deviation)] 18.4 (9.9) 19.9 (9.7) 0.167 19.9 (10.1) 20.0 (9.7) 0.008
Comorbidities
 Hypertension 7574 (44.2) 305 (47.7) 0.069 879 (47.3) 303 (47.6) 0.015
 Diabetes mellitus 1466 (8.6) 72 (11.2) 0.014 203 (10.9) 72 (11.3) 0.009
 History of coronary artery disease 286 (1.7) 12 (1.9) 0.001 33 (1.8) 12 (1.9) 0.012
 History of cerebrovascular disease 703 (4.1) 36 (5.6) 0.008 101 (5.4) 35 (5.5) 0.007
 Liver disease (hepatitis, liver cirrhosis, fatty liver) 434 (2.5) 23 (3.6) 0.057 77 (4.1) 23 (3.6) 0.035
 Chronic obstructive lung disease 734 (4.3) 35 (5.5) 0.006 109 (5.9) 35 (5.5) 0.025
 Chronic kidney disease 2197 (12.8) 152 (23.8) 0.257 416 (22.4) 150 (23.6) 0.016
 Cancer 2914 (17.0) 120 (18.8) 0.045 365 (19.6) 118 (18.6) 0.030
Admitting department 0.214 0.031
 Internal medicine or emergency medicine 3239 (18.9) 132 (20.6) 417 (22.4) 132 (20.8)
 Neurologic center 3485 (20.4) 84 (13.1) 254 (13.7) 84 (13.2)
 Cardiothoracic surgical department 6995 (40.8) 260 (40.6) 727 (39.1) 259 (40.7)
 Other surgical department 3411 (19.9) 164 (25.7) 461 (24.8) 161 (25.3)
Year of ICU discharge 0.099 0.048
 2012 2410 (14.1) 86 (13.4) 254 (13.7) 86 (13.5)
 2013 2933 (17.1) 93 (14.5) 241 (13.0) 93 (14.6)
 2014 3673 (21.4) 165 (25.8) 460 (24.7) 162 (25.5)
 2015 3903 (22.8) 129 (20.2) 399 (21.5) 129 (20.3)
 2016 4211 (24.6) 167 (26.1) 505 (27.1) 166 (26.1)

ICU, intensive care unit; PS, propensity score; ASD, absolute value of standardized mean difference; BMI, body mass index; APACHE, Acute Physiology and Chronic Health Evaluation.

Data are presented as number (percentage) or mean (standard deviation) unless otherwise indicated. Patients in the medical aid program (MAP) were those classified to have low income, and most of their hospital charges were paid by the government. Meanwhile, for patients in the National Health Insurance program (NHIP), approximately two-thirds of their hospital charges were covered by the government.

Table 2

Survival Analysis in the Propensity Score-Matched Cohort

ymj-60-976-i002
Variables 1-year mortality [n/total n (%)] HR (95% CI) p value
Overall 1-year mortality
 National Health Insurance program 289/1859 (15.5) 1
 Medical aid program 127/636 (20.0) 1.31 (1.06, 1.61) 0.012
Sensitivity analysis: Overall 1-year mortality
 National Health Insurance program 289/1859 (15.5) 1
 Medical aid program: Type 1 124/600 (20.7) 1.36 (1.10, 1.68) 0.004
 Medical aid program: Type 2 3/36 (8.3) 0.51 (0.16, 1.60) 0.247
Competing risk analysis
 Cardiovascular 1-year mortality
  National Health Insurance program 37/1859 (2.0) 1
  Medical aid program 17/636 (2.7) 1.36 (0.77, 2.42) 0.290
 Cancer-related 1-year mortality
  National Health Insurance program 122/1859 (6.6) 1
  Medical aid program 52/636 (8.2) 1.27 (0.92, 1.76) 0.145
 Neurologic disease related 1-year mortality
  National Health Insurance program 22/1859 (1.2) 1
  Medical aid program 13/636 (2.0) 1.75 (0.88, 3.48) 0.109
 1-year mortality due to injury or trauma
  National Health Insurance program 15/1859 (0.8) 1
  Medical aid program 9/636 (1.4) 1.79 (0.78, 4.09) 0.168

HR, hazard ratio; CI, confidence interval.

Table 3

Multivariable Cox Regression Model for 1-Year Overall Mortality in Entire Cohort

ymj-60-976-i003
Variables Hazard ratio (95% CI) p value
Insurance: Model 1*
 National Health Insurance program 1
 Medical aid program 1.26 (1.05, 1.51) 0.015
Insurance: Model 2
 National Health Insurance program 1
 Medical aid program: Type 1 1.25 (1.04, 1.51) 0.017
 Medical aid program: Type 2 1.38 (0.44, 4.31) 0.574
Other variables in model 1*
 Age (yr) 1.04 (1.04. 1.05) <0.001
 Body mass index (kg/m2) 0.88 (0.87, 0.89) <0.001
 Sex: male (vs. female) 1.26 (1.14, 1.39) <0.001
 APACHE II 1.02 (1.01, 1.02) <0.001
Highest educational attainment
 Lower than high school 1
 More than or equal to high school, lower than college 1.11 (1.00, 1.23) 0.052
 More than or equal to college 1.01 (0.91, 1.13) 0.798
Marital status
 Never married 1
 Married or living with someone 0.55 (0.44, 0.70) <0.001
 Divorced or separated 0.69 (0.49, 0.96) 0.027
 Widowed 0.65 (0.50, 0.84) 0.001
Comorbidities
 Hypertension 0.90 (0.83, 0.99) 0.033
 Diabetes mellitus 1.06 (0.92, 1.22) 0.404
 History of coronary artery disease 0.77 (0.55, 1.06) 0.105
 History of cerebrovascular disease 1.46 (1.23, 1.72) <0.001
 Liver disease (hepatitis, liver cirrhosis, fatty liver) 1.57 (1.27, 1.95) <0.001
 Chronic obstructive lung disease 1.05 (0.88, 1.26) 0.602
 Chronic kidney disease 1.70 (1.53, 1.88) <0.001
 Cancer 4.85 (4.41, 5.34) <0.001
Admitting department
 Internal medicine or emergency medicine 1
 Neurologic center 0.54 (0.47, 0.63) <0.001
 Cardiothoracic surgical department 0.41 (0.36, 0.46) <0.001
 Other surgical department 0.32 (0.28, 0.37) <0.001
Year of ICU discharge
 2012 1
 2013 0.94 (0.81, 1.10) 0.445
 2014 0.86 (0.75, 0.99) 0.042
 2015 0.74 (0.64, 0.86) <0.001
 2016 0.57 (0.49, 0.66) <0.001

CI, confidence interval; APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit.

*C-index: 0.82 (95% CI: 0.81, 0.83).

TOOLS
Similar articles